Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2022 ∙ Mehrabi Nejad, M. M. Moosaie, F. Dehghanbanadaki, H. Haji Ghadery, A. Shabani, M. Tabary, M. Aryannejad, A. SeyedAlinaghi, S. Rezaei, N.

Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Luo, N. Chen, X. Du, J. Mei, B. Wang, A. Kuang, F. Fang, C. Gan, Y. Peng, F. Yang, X. Dahmen, U. Li, B. Song, S.

Immunogenicity of COVID-19 vaccines in chronic liver disease patients and liver transplant recipients: a systematic review and meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Boroumand, A. B. Forouhi, M. Karimi, F. Moghadam, A. S. Naeini, L. G. Kokabian, P. Naderi, D.

Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Cho, K. Park, S. Kim, E. Y. Koyanagi, A. Jacob, L. Yon, D. K. Lee, S. W. Kim, M. S. Radua, J. Elena, D. Il Shin, J. Smith, L.

Immunogenicity of COVID-19 Vaccines in Patients with Diverse Health Conditions: a Comprehensive Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Chen, X. Luo, D. Mei, B. Du, J. Liu, X. Xie, H. Liu, L. Su, S. Mai, G.

Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Chuleerarux, N. Manothummetha, K. Moonla, C. Sanguankeo, A. Kates, O. S. Hirankarn, N. Phongkhun, K. Thanakitcharu, J. Leksuwankun, S. Meejun, T. Thongkam, A. Mongkolkaew, T. Dioverti, M. V. Torvorapanit, P. Langsiri, N. Worasilchai, N. Plongla, R. Chindamporn, A. Gopinath, S. Nissaisorakarn, P. Thaniyavarn, T. Nematollahi, S. Permpalung, N.

Immunogenicity of SARS-CoV-2 vaccines in patients with multiple myeloma: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Yang, X. Zhang, H. Bao, W. Fu, S. Jin, H.

Immunogenicity Rates after SARS-CoV-2 Three-Dose Vaccination in Patients under Dialysis: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Tang, K. T. Hsu, B. C. Chen, D. Y.

Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Yang, B. Huang, X. Gao, H. Leung, N. H. Tsang, T. K. Cowling, B. J.

Immunogenicity, efficacy, and safety of SARS-CoV-2 vaccine dose fractionation: a systematic review and meta-analysis

  • Children
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Sadeghi, Sara Kalantari, Yasamin Shokri, Sima Fallahpour, Morteza Nafissi, Nahid Goodarzi, Azadeh Valizadeh, Rohollah

Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis

  • Children
  • Adolescents
  • Adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...